COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Indiana patients with a documented clinical need may be eligible for compounded tirzepatide.
Indiana’s healthcare is anchored by Indianapolis, home to Eli Lilly — the manufacturer of Mounjaro and Zepbound. Compounding Finder helps Indiana residents compare licensed pharmacies that ship statewide.
Yes. The Indiana Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.